News

Biotech

Preclinical study demonstrates long-term success of allogeneic islet implantation for diabetes

LessDeath is planning for a post-aging future

On the record – modified bacteria can capture gut health status

But bacteria with data logger functionality could be a noninvasive means of diagnosing disease or assessing the impact of a diet on health.

Juvenescence and Buck Institute launch company to target heart disease

Plug-and-play organ-on-a-chip can be customised patient-by-patient

Startup boasts multiple novel compounds with potential to halt progress of age-related disease

Genflow Biosciences moves into cellular reprogramming

Small but mighty – how nanobodies are fighting chronic inflammation

New lab grown miniature heart that can beat by itself

YouthBio CEO: The time is right to develop epigenetic reprogramming therapies

Strategic collaboration set to develop an iPSC-derived cell therapy platform

Japan university tackles aging with transplanted pluripotent stem cells

MitoRx Therapeutics lands funding to target mitochondrial dysfunction and age-related disease

Juvenescence and Buck Institute set the (ke)tone for metabolism and ketosis research

James Peyer: Geroscience evidence is the key to unlocking preventative therapies

BioAge announces first cohort dosed in Phase 1b clinical trial of muscle aging therapy

Active ingredient in Juvenescence’s Metabolic Switch induces ketosis, new study finds

Low-dose lithium could slow kidney aging, new research finds

YouthBio Therapeutics: New epigenetic rejuvenation startup emerges from stealth

James Peyer on breaking the geroscience dam

Andrew Steele: Our goal must be to cure aging

We need a better understanding of senescence to build better senolytics

SENISCA – targeted interventions that boast exquisite specificity

Research reverses aging in human skin cells by 30 years

Serpin therapy has fibrosis in its sights with clinical trial slated for 2023

Swiss scientists crack muscle recovery, repairing age-related fatigue

Fauna Bio partners with UW Oshkosh in search for novel therapies for disease

Focus on frailty: New senolytic holds potential for sarcopenia treatment

Rejuvenate Biomed starts groundbreaking sarcopenia trial with eye on future growth

Insilico identifies therapeutic targets implicated in aging using AI and hallmarks of aging framework

Genflow collaborates with Aging Research Centre to drive sirtuin research

Strategic partnership plans disruptive, personalised AI engine to counter skin aging

Find us here ...